Benzopyranyl-3-alcohol esterified derivative serving as antineoplastic multidrug resistance inhibitor and preparation method and application of benzopyranyl-3-alcohol esterified derivative
A technology of benzopyran and multidrug resistance, which is applied in the field of medicine, can solve the problems of chemical and biological metabolism instability, low antitumor multidrug resistance activity, etc., and achieve good antitumor multidrug resistance activity, good selective effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] Example 1: Preparation of 5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-chromen-3-ol, 3,4, 5-trimethoxybenzoate (shown in 3 in the synthetic route structure diagram).
[0034] Add 2.0 g, 2.5 mmol of peracetylated epigallocatechin gallate to 50 mL of saturated hydrogen chloride in methanol, the solid slowly dissolves, and the solution appears pale yellow. The reaction was stirred at room temperature for 12 h, the color of the solution gradually deepened, and finally turned into wine red, and the reaction was complete as detected by TLC. The reaction solution was rotary evaporated to remove methanol to obtain epigallocatechin gallate (EGCG). EGCG was not further purified, and 100 mL of ethylene glycol dimethyl ether-acetone mixed solvent was added to dissolve it completely, and then 7.5 g of potassium carbonate and 10 mL of dimethyl sulfate were added. Heated to reflux for 48 h and evaporated to dryness. Wash with saturated sodium carbonate solution 3 times, and...
Embodiment 2
[0036] Example 2: Preparation of 5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-chromene-3-ol (synthetic route structure diagram shown in 4).
[0037] The 5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-chromene-3-ol prepared in Example 1, 3,4 , 5-trimethoxybenzoate (0.50 g, 0.86 mmol) was dissolved in a mixed solvent of 10 mL methanol and 10 mL ethylene glycol dimethyl ether, and then 0.2 g K 2 CO 3 , the reaction was stirred at room temperature, and the progress of the reaction was detected by TLC. After 1 h, the starting material disappeared. Evaporate to dryness to obtain a white solid, add 20 mL of ethyl acetate, filter off the insoluble matter, concentrate by rotary evaporation, and separate by silica gel column chromatography (ethyl acetate: petroleum ether = 1: 4) to obtain 0.28 g of product, yield: 87% .
[0038] 1 H NMR (CDCl 3 , 500 MHz) δ(ppm): 6.70 (s, 2 H), 6.31 ( d, J =8.0 Hz, 1 H), 6.13 ( d, J =8.0 Hz, 1 H), 6.59-6.57 (m, 1 H), 5.03-5.01 (m, ...
Embodiment 3
[0039] Example 3: Preparation of 5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-chromen-3-ol, 4-methoxy Base benzoate (shown in 5 in the synthetic route structure diagram).
[0040] Take 4-methoxybenzoic acid (0.18 g, 1.18 mmol) and 5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-benzo Pyran-3-ol (200mg, 0.53mmol), then add p-dimethylaminopyridine (0.26 g, 2.15 mmol) and 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride (0.29 g, 2.15 mmol), under nitrogen protection, dissolved in 20 ml of anhydrous dichloromethane, stirred at room temperature for 24 h to complete the reaction. Washed three times with saturated sodium bicarbonate solution, collected the organic phase, dried over anhydrous magnesium sulfate for 4 h, and spin-dried to obtain the crude product, which was separated by column (petroleum ether / ethyl acetate=3 / 1 v / v) to obtain 0.18 g of pure product , yield 68%.
[0041] 1 H NMR (CDCl 3 , 500 MHz) δ (ppm): 7.56-7.55 (m, 1 H), 7.54 (s, 1 H), 7...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com